Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-15

Clinical Trial Update: Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

View source ↗

Summary

This document provides an update on the TRAIL Study, a clinical trial evaluating risk modeling for tricuspid regurgitation, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-sen University | Conditions: Tricuspid Regurgitation | Status: RECRUITING